Tempus AI, Inc.

TEM Healthcare Health Information Services

Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.

Revenue
+23.1%
EPS
+82.2%
Free cash flow
+95.7%
Total debt
+8.44%

Quarter to September 2026, against a year earlier

76.26 5.83 +8.28%
Market cap
$12.9B
P/E
0.0×
Fwd P/E
−51.8×
Dividend yield
—
F-score
4/9
Altman Z
2.60
Beneish M
−1.25
Dividend safety
n/a

Tempus AI, Inc. (TEM) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Tempus AI, Inc. (TEM) trades at a P/S ratio of 8.5×. Over the past ten years it has ranged from 2.8× (June 2024) to 20.1× (November 2024); the current reading is higher than 43% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 8.1× 38.66%
FY2024 5.8× 28.45%
FY2023 4.5× 0.00%
FY2022 4.5× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 9.8× 35.17%
Jun 2026 7.3× 22.75%
Mar 2026 5.9× (26.72%)
Dec 2025 8.1× (36.66%)
11 more quarters

Against its own ten years

Low 2.8× High 20.1×
Ten-year median 9.1×
Current reading's percentile 43

P/S ratio against peers

Company P/S ratio
BTSG BrightSpring Health Services, Inc. compare 0.9×
PRVA Privia Health Group, Inc. compare 1.2×
WAY Waystar Holding Corp. compare 4.4×
HQY HealthEquity, Inc. compare 6.3×
TEM Tempus AI, Inc. 8.5×
DOCS Doximity, Inc. compare 9.0×
HNGE Hinge Health Inc. compare 12.7×
VEEV Veeva Systems Inc. compare 14.5×
HTFL Heartflow, Inc. compare 21.3×
Health Information Services industry median 1.8×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on TEM